Drugs / Sabin strain inactivated poliovirus vaccine (Vero cell)
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT03822767 | Jun → Sep 2018 | poliomyelitis | Sinovac Biotech Co., Ltd | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Sabin strain inactivated poliovirus vaccine (Vero cell) | “The investigational Sabin strain inactivated poliovirus vaccine (Vero cell)(sIPV) was manufactured by Sinovac Biotech Co., Ltd .” NCT03822767 ↗ |
| Known as | sIPV | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03822767 ↗ |
| Modality | Vaccine | “The investigational Sabin strain inactivated poliovirus vaccine (Vero cell)(sIPV) was manufactured by Sinovac Biotech Co., Ltd .” NCT03822767 ↗ |
| Route | Intramuscular | “Two intramuscular injections of the investigational vaccine (0.5 ml) on Day 0 and Day 30 respectively” NCT03822767 ↗ |